跳至主要内容
临床试验/NCT07226804
NCT07226804招募中不适用

Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules

M.D. Anderson Cancer Center2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年11月14日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
Quality-of-life Questionnaire

研究概览

简要总结

To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.

详细描述

Primary Objectives

• To evaluate the thyroid nodule volume changes over time in participants undergoing nsPFA as part of routine clinical care

Secondary Objectives

  • To determine changes in health-related quality of life changes following ultrasound-guided nsPFA
  • To evaluate the ultrasound features of thyroid nodules over time following ultrasound-guided nsPFA.
  • To assess the incidence and nature of complications following ultrasound-guided nsPFA, categorized into Minor and Major complications.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligibility Criteria
  • Scheduled to undergo ultrasound guided nsPFA as standard of care
  • Age 18 to 80 years.
  • Capable of providing independent consent.
  • Presence of biopsy-confirmed benign thyroid nodule , defined as one of the following:
  • Benign FNA X 2 or
  • Benign US guided FNA X 1 + benign thyroid nodule ultrasound appearance (TI-RADS 2) or
  • Benign FNA X 1 and radiographic/laboratory evidence of functional nature
  • Nodule measuring >2cm in greatest dimension
  • Presence of compressive symptoms reasonably attributable to thyroid nodule (i.e. pressure sensation, dysphagia, dysphonia, respiratory distress)
  • No abnormal cervical lymph nodes during screening visit .

排除标准

  • Patients considered unsuitable for nsPFA by the treating physician

结局指标

主要结局

Quality-of-life Questionnaire

时间窗: Through study completion; an average of 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Nanosecond Pulsed Field Ablation in the Management... | 临床试验